Literature DB >> 18848642

Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.

Leif Smith1, Jd Hillman.   

Abstract

Type A (I) lantibiotics are cationic antimicrobial peptides that have a potential usefulness in treating infectious diseases. They are known to have a potent and broad spectrum of activity, an insignificant cytotoxicity, and demonstrated efficacy in animal infection models, suggesting therapeutic potential. In this review, topics pertaining to their basic structure, mode of bactericidal activity, pharmacology, and methods of manufacture are described.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18848642      PMCID： PMC2603291          DOI： 10.1016/j.mib.2008.09.008

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.934


  52 in total

1.  The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.

Authors:  Shang-Te D Hsu; Eefjan Breukink; Eugene Tischenko; Mandy A G Lutters; Ben de Kruijff; Robert Kaptein; Alexandre M J J Bonvin; Nico A J van Nuland
Journal:  Nat Struct Mol Biol       Date:  2004-09-12       Impact factor: 15.369

2.  An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

Authors:  Hester E Hasper; Naomi E Kramer; James L Smith; J D Hillman; Cherian Zachariah; Oscar P Kuipers; Ben de Kruijff; Eefjan Breukink
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

Review 3.  Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.

Authors:  H G Sahl; G Bierbaum
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

4.  Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.

Authors:  Sam Maher; Siobhán McClean
Journal:  Biochem Pharmacol       Date:  2006-03-13       Impact factor: 5.858

5.  Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3.

Authors:  G Engelke; Z Gutowski-Eckel; P Kiesau; K Siegers; M Hammelmann; K D Entian
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

6.  The effect of nisin on murein synthesis.

Authors:  P Reisinger; H Seidel; H Tschesche; W P Hammes
Journal:  Arch Microbiol       Date:  1980-10       Impact factor: 2.552

7.  Additional antibiotic inhibitors of peptidoglycan synthesis.

Authors:  P E Linnett; J L Strominger
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

8.  Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles.

Authors:  A J Driessen; H W van den Hooven; W Kuiper; M van de Kamp; H G Sahl; R N Konings; W N Konings
Journal:  Biochemistry       Date:  1995-02-07       Impact factor: 3.162

9.  Physiochemical characterization of the nisin-membrane interaction with liposomes derived from Listeria monocytogenes.

Authors:  K Winkowski; R D Ludescher; T J Montville
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

10.  Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants.

Authors:  T Kupke; F Gotz
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490
View more
  24 in total

Review 1.  Importance of microbial natural products and the need to revitalize their discovery.

Authors:  Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2013-08-30       Impact factor: 3.346

2.  Surface glycosaminoglycans protect eukaryotic cells against membrane-driven peptide bacteriocins.

Authors:  Rebeca Martín; Susana Escobedo; Carla Martín; Ainara Crespo; Luis M Quiros; Juan E Suarez
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

3.  Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile-Associated Infection.

Authors:  Mark E Pulse; William J Weiss; Johan A Kers; Anthony W DeFusco; Jae H Park; Martin Handfield
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Construction, heterologous expression, partial purification, and in vitro cytotoxicity of the recombinant plantaricin E produced by Lactococcus lactis against Enteropathogenic Escherichia coli K.1.1 and human cervical carcinoma (HeLa) cells.

Authors:  Apon Zaenal Mustopa; Siti Mariyah; Sri Budiarti; Hidayah Murtiyaningsih; Wida Nurul Alfisyahrin
Journal:  Mol Biol Rep       Date:  2018-07-31       Impact factor: 2.316

5.  Characterization of the stereochemical configuration of lanthionines formed by the lanthipeptide synthetase GeoM.

Authors:  Neha Garg; Yuki Goto; Ting Chen; Wilfred A van der Donk
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

6.  In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance.

Authors:  Katy L Blake; Chris P Randall; Alex J O'Neill
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

7.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

8.  Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.

Authors:  Misty L Kuhn; Prachi Prachi; George Minasov; Ludmilla Shuvalova; Jiapeng Ruan; Ievgeniia Dubrovska; James Winsor; Monica Giraldi; Massimiliano Biagini; Sabrina Liberatori; Silvana Savino; Fabio Bagnoli; Wayne F Anderson; Guido Grandi
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

9.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

Review 10.  Biomedical applications of nisin.

Authors:  J M Shin; J W Gwak; P Kamarajan; J C Fenno; A H Rickard; Y L Kapila
Journal:  J Appl Microbiol       Date:  2016-02-12       Impact factor: 3.772
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.